Related references
Note: Only part of the references are listed.Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease
Juliet M. Taylor et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
The Reactome Pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2018)
FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus
Dongyan Shi et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus
Shweta Jain et al.
FRONTIERS IN IMMUNOLOGY (2018)
Effects of fingolimod administration in a genetic model of cognitive deficits
D. Becker-Krail et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
被撤回的出版物: Microglia-dependent synapse loss in type I interferon-mediated lupus (Retracted article. See vol. 578, pg. 177, 2020)
Allison R. Bialas et al.
NATURE (2017)
The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface
Ariel D. Stock et al.
AUTOIMMUNITY REVIEWS (2017)
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
Samuel F. Hunter et al.
CNS DRUGS (2016)
Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus
H. Fragoso-Loyo et al.
LUPUS (2016)
Type-1 Interferons Contribute to the Neuroinflammatory Response and Disease Progression of the MPTP Mouse Model of Parkinson's Disease
Bevan S. Main et al.
GLIA (2016)
B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus
Jing Wen et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
Samuel F. Hunter et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Neuropsychiatric lupus: a mosaic of clinical presentations
Shaye Kivity et al.
BMC MEDICINE (2015)
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation
Andres Miguez et al.
HUMAN MOLECULAR GENETICS (2015)
Endogenous IFN-β signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia
Ana R. Inacio et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory
P. Efstathopoulos et al.
TRANSLATIONAL PSYCHIATRY (2015)
Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis
Hideaki Nishihara et al.
PLOS ONE (2015)
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Simona F. Spampinato et al.
PLOS ONE (2015)
Antidepressant activity of fingolimod in mice
Luigi di Nuzzo et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Fingolimod May Support Neuroprotection via Blockade of Astrocyte Nitric Oxide
Emanuela Colombo et al.
ANNALS OF NEUROLOGY (2014)
Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: The MRL-lpr mouse strain as a model
Helene Jeltsch-David et al.
AUTOIMMUNITY REVIEWS (2014)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review
Savino Sciascia et al.
JOURNAL OF NEUROLOGY (2014)
Blocking Lymphocyte Trafficking with FTY720 Prevents Inflammation-Sensitized Hypoxic-Ischemic Brain Injury in Newborns
Dianer Yang et al.
JOURNAL OF NEUROSCIENCE (2014)
Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice
Jesse Brodkin et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory
Nitai C. Hait et al.
NATURE NEUROSCIENCE (2014)
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Helene Jeltsch-David et al.
NATURE REVIEWS NEUROLOGY (2014)
Diagnosis and management of neuropsychiatric SLE
John G. Hanly
NATURE REVIEWS RHEUMATOLOGY (2014)
The Reactome pathway knowledgebase
David Croft et al.
NUCLEIC ACIDS RESEARCH (2014)
Immunomodulatory activity of interferon-beta
Lloyd H. Kasper et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
CNS-specific T cells shape brain function via the choroid plexus
Kuti Baruch et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway
Jing Wen et al.
JOURNAL OF AUTOIMMUNITY (2013)
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
Masoumeh Asle-Rousta et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
Hiromi Noda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE
Monica Moreno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier
Chaodong Wang et al.
MOLECULAR IMMUNOLOGY (2013)
Epigenetics of the Depressed Brain: Role of Histone Acetylation and Methylation
HaoSheng Sun et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Fingolimod protects cultured cortical neurons against excitotoxic death
Luisa Di Menna et al.
PHARMACOLOGICAL RESEARCH (2013)
Neuropsycniatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway
Ariel D. Stock et al.
FRONTIERS IN IMMUNOLOGY (2013)
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
J. G. Hanly et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution
Emmanuelle Briard et al.
CHEMMEDCHEM (2011)
The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
Maria Gulinello et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Animal Models of MS RevealMultiple Roles of Microglia in Disease Pathogenesis
Zhen Gao et al.
NEUROLOGY RESEARCH INTERNATIONAL (2011)
FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice
Seiichiro Ando et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Sphingosine 1-Phosphate Receptor 1 and 3 Are Upregulated in Multiple Sclerosis Lesions
Ruben Van Doorn et al.
GLIA (2010)
Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
Hiroshi Okamoto et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats
Yan Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Changing Worldwide Epidemiology of Systemic Lupus Erythematosus
Archana Vasudevan et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Guillermo J. Pons-Estel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Prevalence of Mood and Anxiety Disorders in Women With Systemic Lupus Erythematosus
Elizabeth A. Bachen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
Carolyn A. Foster et al.
BRAIN PATHOLOGY (2009)
Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study
Shunsei Hirohata et al.
CLINICAL RHEUMATOLOGY (2009)
Depression is an early disease manifestation in lupus-prone MRL/lpr mice
Hua-Xin Gao et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
The vascular S1P gradient - Cellular sources and biological significance
Timothy Hla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure
Barbara Metzler et al.
INTERNATIONAL IMMUNOLOGY (2008)
Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis
Hilda Fragoso-Loyo et al.
PLOS ONE (2008)
Interferon-β is neuroprotective against the toxicity induced by activated microglia
Shijie Jin et al.
BRAIN RESEARCH (2007)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
New immunosuppresor strategies in the treatment of murine lupus nephritis
G. Alperovich et al.
LUPUS (2007)
Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice
Xiaoxing Ma et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Long-term prognosis and causes of death in systemic lupus erythematosus
Andrea Doria et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors
R Omdal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
M Webb et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Hippocampal damage in mouse and human forms of systemic autoimmune disease
DA Ballok et al.
HIPPOCAMPUS (2004)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Limitations on the use of the C57BL/6 mouse in the tail suspension test
AJ Mayorga et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
